查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1625446

动物抗生素市场、占有率、规模、趋势、行业分析报告（按动物类型、药物类别、剂型和地区）- 市场预测，2025-2034 年

Veterinary Antibiotics Market Share, Size, Trends, Industry Analysis Report: By Animal Type, Drug Class, Dosage Form, and Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 122 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的一项新研究，全球兽用抗生素市场规模预计到 2034 年将达到 64.3 亿美元。该报告提供了有关当前市场动态的详细见解，并对未来市场的成长进行了分析。

兽用抗生素是专门用于治疗动物细菌感染的药物。抗生素透过消除或抑制有害细菌的生长来帮助动物恢復。

由于各大公司的措施和新产品的推出，兽用抗生素和离子载体越来越受到关注。牲畜疾病不断增加，各大公司都在积极推出新型抗生素以满足需求。

由于人们对人畜共患疾病认识的不断提高、动物疾病发病率的不断上升以及对动物源性食品的需求不断增加，预计预测期内兽用抗生素市场将出现增长。此外，严格的疾病预防法规、不断增长的动物数量、不断增加的宠物拥有量以及不断扩大的宠物健康保险市场正在推动市场成长。

伴侣动物拥有量的增加推动了对兽医服务和产品（包括抗生素）的需求。随着越来越多的人将宠物带入家中，全球对这些动物的医疗保健、预防性护理和治疗的需求持续增加。

根据2024年7月中央疾病管制报告，预防在动物和人之间传播的人畜共通传染病需要采取 "同一个健康" 方法进行有效控制。值得注意的是，人类60%的传染病源自于动物，包括爱滋病毒、狂犬病等病原体。此外，大多数新兴传染病和80%的生物恐怖主义相关疾病（如炭疽病）都是人畜共通的。动物中此类疾病发生率的不断上升推动了兽用抗生素市场的扩张。

动物抗生素报告重点

按动物类型划分，2024 年牛类占据兽用抗生素市场的主导地位，这是由于牛肉和乳製品消费量的增加需要加强动物健康管理。

依药物类别划分，四环素类药物因其治疗用途在 2024 年占据市场主导地位。这些抗生素被广泛用作食用动物的第一线治疗，并经常用于治疗狗、猫和马等伴侣动物。四环素类药物，例如阿克罗霉素、苏米星、美迪环素和四环素，用于兽医学，特别是用于对抗动物的细菌感染和发炎性皮肤病。

由于在宠物护理（包括食品、医疗保健和美容）方面的支出很高，预计未来几年欧洲兽医市场将会成长。此外，智慧宠物设备等技术进步也促进了市场的成长。消费者偏好的变化，尤其是对饮食和素食宠物食品的需求不断增加，也支持了市场的成长。

全球市场的一些主要参与者包括 Merck &Co., Inc.、Ceva Sante Animale、Vetoquinol、Zoetis Services LLC、Boehringer Ingelheim International GmbH、Dechra Pharmaceuticals PLC、Elanco Animal Health Incorporated、Virbac S.A.、Calier、Bimeda Inc. 、Prodivet Pharmaceuticals SA/NV 和Norbrook Laboratories。

目录

第 1 章简介

第 2 章执行摘要

第 3 章 研究方法

第 4 章。
  • 市场概况
  • 动物抗生素市场动态
    • 推动因素和机遇
      • 对动物性食品的需求不断增加
      • 牲畜疾病发生率增加
    • 阻碍因素和课题
      • 强而有力的监管框架
  • PESTEL 分析
  • 动物抗生素市场的趋势
  • 价值链分析
  • COVID-19 影响分析

5. 全球动物抗生素市场（以动物类型）

  • 主要发现
  • 简介
  • 猪
  • 牛
  • 绵羊和山羊
  • 家禽
  • 其他

6. 全球动物抗生素市场（依药物类别）

  • 主要发现
  • 简介
  • 四环素
  • 青霉素
  • 磺胺类药物
  • 大环内酯类
  • 甲氧芐啶 林可酰胺类
  • 多粘菌素
  • 氨基糖甘类
  • 氟奎诺酮类药物
  • 截短侧耳素
  • 其他

7. 全球动物抗生素市场（以剂型划分）

  • 主要发现
  • 简介
  • 口服粉
  • 口服溶液
  • 注入
  • 其他

8. 全球动物抗生素市场（按地区）

  • 主要发现
  • 简介
    • 动物抗生素市场评估：地区，2020-2034 年
  • 北美洲
    • 2020 年至 2034 年，北美各动物类型
    • 北美：依药物类别，2020 年至 2034 年
    • 2020 年至 2034 年，北美以剂型划分
    • 美国
    • 加拿大
  • 欧洲
      2020 年至 2034 年欧洲各动物类型 欧洲：依药物类别划分，2020 年至 2034 年 欧洲：依剂型划分，2020-2034 年
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲国家
    亚太地区
      亚太地区，依动物类型，2020-2034 年 亚太地区，依药物类别，2020 年至 2034 年 2020 年至 2034 年亚太地区剂型分类
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲
      中东和非洲：依动物类型，2020-2034 年 中东和非洲：毒品类别，2020 年至 2034 年 中东和非洲：按剂型划分，2020 年至 2034 年
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东和非洲地区
  • 拉丁美洲
    • 拉丁美洲，依动物类型，2020 年至 2034 年 2020 年至 2034 年拉丁美洲各毒品类别
    • 2020 年至 2034 年拉丁美洲按剂型划分的情况
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他拉丁美洲国家

第 9 章 竞争格局

  • 扩张与收购分析
    • 放大
    • 收购
  • 伙伴关係/协作/协定/揭露

第十章 公司简介

  • Bimeda, Inc.
  • Boehringer Ingelheim International GmbH
  • Calier
  • Ceva Sante Animale
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Merck & Co., Inc.
  • Norbrook Laboratories
  • Prodivet Pharmaceuticals SA/NV
  • Vetoquinol
  • Virbac S.A.
  • Zoetis Services LLC
Product Code: PM5317

The global veterinary antibiotics market size is expected to reach USD 6.43 billion by 2034, according to a new study by Polaris Market Research. The report "Veterinary Antibiotics Market Share, Size, Trends, Industry Analysis Report: By Animal Type (Pigs, Cattle, Sheep & Goats, Poultry, and Others), Drug Class, Dosage Form, and Region (North America, Europe, Asia Pacific, and Rest of World) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Veterinary antibiotics are medications specifically designed for treating bacterial infections in animals. The antibiotics eliminate harmful bacteria or inhibit their growth, thus assisting in the animal's recovery.

There is a growing emphasis on animal-specific antibiotics and ionophores, driven by initiatives from major companies and the introduction of new products. The incidence of livestock diseases is on the rise, leading key players to actively release new antibiotics to meet demand, especially as older antibiotics have been linked to resistance.

The veterinary antibiotics market is expected to grow during the forecast period due to increased awareness of zoonotic diseases, rising animal disease outbreaks, and higher demand for animal-derived food products. Additionally, stringent disease prevention regulations, a growing animal population, increased pet adoption, and the expanding pet health insurance market are driving the market growth.

The increasing adoption of companion animals is propelling the demand for veterinary services and products, including antibiotics. As more people bring pets into their homes, the need for healthcare, preventive measures, and treatments for these animals continues to increase globally.

According to the central disease control report in July 2024, prevention of Zoonotic diseases, which are transmissible between animals and humans, requires a One Health approach for effective management. Notably, 60% of human infectious diseases originate from animals, including pathogens such as HIV and rabies. Additionally, most emerging infectious diseases and 80% of bioterrorism-related diseases, such as anthrax, are zoonotic. The increasing incidence of such diseases among animals boosts the veterinary antibiotics market expansion.

Veterinary Antibiotics Report Highlights

By animal type, the cattle segment dominated the veterinary antibiotics market in 2024 due to the rising consumption of beef and dairy products that necessitate enhanced animal health management.

Based on drug class, in 2024, the tetracyclines segment dominated the market due to their therapeutic applications. These antibiotics are widely used as first-line treatments for food-producing animals and are also frequently administered to companion animals, including dogs, cats, and horses. Tetracycline-based medications such as Achromycin, Sumycin, Medicycline, and Tetracyn are specifically used in veterinary medicine to address bacterial infections and inflammatory skin conditions in animals.

The European veterinary market is expected to grow in the coming years due to the high expenditure on pet care, encompassing food, healthcare, and grooming. Furthermore, technological advancements such as smart pet devices are contributing to the market growth. Shifting consumer preferences, particularly the increasing demand for dietary and vegan pet food, also support the market growth.

A few global key market players are Merck & Co., Inc.; Ceva Sante Animale; Vetoquinol; Zoetis Services LLC; Boehringer Ingelheim International GmbH; Dechra Pharmaceuticals PLC; Elanco Animal Health Incorporated; Virbac S.A.; Calier, Bimeda, Inc.; Prodivet Pharmaceuticals SA/NV; and Norbrook Laboratories.

Polaris Market Research has segmented the veterinary antibiotics market report on the basis of animal type, drug class, dosage form, and region:

By Animal Type Outlook (Revenue, USD Billion, 2020-2034)

  • Pigs
  • Cattle
  • Sheep & Goats
  • Poultry
  • Others

By Drug Class Outlook (Revenue, USD Billion, 2020-2034)

  • Tetracyclines
  • Penicillins
  • Sulfonamides
  • Macrolides
  • Trimethoprim
  • Lincosamides
  • Polymyxins
  • Aminoglycosides
  • Fluoroquinolones
  • Pleuromutilins
  • Other

By Dosage Form Outlook (Revenue, USD Billion, 2020-2034)

  • Oral Powders
  • Oral Solutions
  • Injections
  • Other

By Regional Outlook (Revenue, USD Billion, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global Veterinary Antibiotics Market Insights

  • 4.1. Veterinary Antibiotics Market - Market Snapshot
  • 4.2. Veterinary Antibiotics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Demand for Animal-Derived Food Products
      • 4.2.1.2. Increasing Incidence of Livestock Diseases
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Strict regulatory framework
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Veterinary Antibiotics Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Veterinary Antibiotics Market, by Animal Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
  • 5.3. Pigs
    • 5.3.1. Global Veterinary Antibiotics Market, by Pigs, by Region, 2020-2034 (USD Billion)
  • 5.4. Cattle
    • 5.4.1. Global Veterinary Antibiotics Market, by Cattle, by Region, 2020-2034 (USD Billion)
  • 5.5. Sheep & Goats
    • 5.5.1. Global Veterinary Antibiotics Market, by Sheep & Goats, by Region, 2020-2034 (USD Billion)
  • 5.6. Poultry
    • 5.6.1. Global Veterinary Antibiotics Market, by Poultry, by Region, 2020-2034 (USD Billion)
  • 5.7. Others
    • 5.7.1. Global Veterinary Antibiotics Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Veterinary Antibiotics Market, by Drug Class

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
  • 6.3. Tetracyclines
    • 6.3.1. Global Veterinary Antibiotics Market, by Tetracyclines, by Region, 2020-2034 (USD Billion)
  • 6.4. Penicillins
    • 6.4.1. Global Veterinary Antibiotics Market, by Penicillins, by Region, 2020-2034 (USD Billion)
  • 6.5. Sulfonamides
    • 6.5.1. Global Veterinary Antibiotics Market, by Sulfonamides, by Region, 2020-2034 (USD Billion)
  • 6.6. Macrolides
    • 6.6.1. Global Veterinary Antibiotics Market, by Macrolides, by Region, 2020-2034 (USD Billion)
  • 6.7. Trimethoprim
    • 6.7.1. Global Veterinary Antibiotics Market, by Trimethoprim, by Region, 2020-2034 (USD Billion)
  • 6.8. Lincosamides
    • 6.8.1. Global Veterinary Antibiotics Market, by Lincosamides, by Region, 2020-2034 (USD Billion)
  • 6.9. Polymyxins
    • 6.9.1. Global Veterinary Antibiotics Market, by Polymyxins, by Region, 2020-2034 (USD Billion)
  • 6.10. Aminoglycosides
    • 6.10.1. Global Veterinary Antibiotics Market, by Aminoglycosides, by Region, 2020-2034 (USD Billion)
  • 6.11. Fluoroquinolones
    • 6.11.1. Global Veterinary Antibiotics Market, by Fluoroquinolones, by Region, 2020-2034 (USD Billion)
  • 6.12. Pleuromutilins
    • 6.12.1. Global Veterinary Antibiotics Market, by Pleuromutilins, by Region, 2020-2034 (USD Billion)
  • 6.13. Others
    • 6.13.1. Global Veterinary Antibiotics Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Veterinary Antibiotics Market, by Dosage Form

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
  • 7.3. Oral Powders
    • 7.3.1. Global Veterinary Antibiotics Market, by Oral Powders, by Region, 2020-2034 (USD Billion)
  • 7.4. Oral Solutions
    • 7.4.1. Global Veterinary Antibiotics Market, by Oral Solutions, by Region, 2020-2034 (USD Billion)
  • 7.5. Injections
    • 7.5.1. Global Veterinary Antibiotics Market, by Injections, by Region, 2020-2034 (USD Billion)
  • 7.6. Others
    • 7.6.1. Global Veterinary Antibiotics Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Veterinary Antibiotics Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Veterinary Antibiotics Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. Veterinary Antibiotics Market - North America
    • 8.3.1. North America: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
    • 8.3.2. North America: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
    • 8.3.3. North America: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.3.4. Veterinary Antibiotics Market - U.S.
      • 8.3.4.1. U.S.: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.3.4.2. U.S.: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.3.4.3. U.S.: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.3.5. Veterinary Antibiotics Market - Canada
      • 8.3.5.1. Canada: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
  • 8.4. Veterinary Antibiotics Market - Europe
    • 8.4.1. Europe: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.4.4. Veterinary Antibiotics Market - UK
      • 8.4.4.1. UK: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.4.5. Veterinary Antibiotics Market - France
      • 8.4.5.1. France: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.4.6. Veterinary Antibiotics Market - Germany
      • 8.4.6.1. Germany: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.4.7. Veterinary Antibiotics Market - Italy
      • 8.4.7.1. Italy: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.4.8. Veterinary Antibiotics Market - Spain
      • 8.4.8.1. Spain: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.4.9. Veterinary Antibiotics Market - Netherlands
      • 8.4.9.1. Netherlands: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.4.10. Veterinary Antibiotics Market - Russia
      • 8.4.10.1. Russia: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.4.11. Veterinary Antibiotics Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
  • 8.5. Veterinary Antibiotics Market - Asia Pacific
    • 8.5.1. Asia Pacific: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.5.4. Veterinary Antibiotics Market - China
      • 8.5.4.1. China: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.5.5. Veterinary Antibiotics Market - India
      • 8.5.5.1. India: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.5.6. Veterinary Antibiotics Market - Malaysia
      • 8.5.6.1. Malaysia: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.5.7. Veterinary Antibiotics Market - Japan
      • 8.5.7.1. Japan: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.5.8. Veterinary Antibiotics Market - Indonesia
      • 8.5.8.1. Indonesia: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.5.9. Veterinary Antibiotics Market - South Korea
      • 8.5.9.1. South Korea: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.5.10. Veterinary Antibiotics Market - Australia
      • 8.5.10.1. Australia: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.5.11. Veterinary Antibiotics Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
  • 8.6. Veterinary Antibiotics Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.6.4. Veterinary Antibiotics Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.6.5. Veterinary Antibiotics Market - UAE
      • 8.6.5.1. UAE: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.6.6. Veterinary Antibiotics Market - Israel
      • 8.6.6.1. Israel: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.6.7. Veterinary Antibiotics Market - South Africa
      • 8.6.7.1. South Africa: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.6.8. Veterinary Antibiotics Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
  • 8.7. Veterinary Antibiotics Market - Latin America
    • 8.7.1. Latin America: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.7.4. Veterinary Antibiotics Market - Mexico
      • 8.7.4.1. Mexico: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.7.5. Veterinary Antibiotics Market - Brazil
      • 8.7.5.1. Brazil: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.7.6. Veterinary Antibiotics Market - Argentina
      • 8.7.6.1. Argentina: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)
    • 8.7.7. Veterinary Antibiotics Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Bimeda, Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Boehringer Ingelheim International GmbH
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Calier
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Ceva Sante Animale
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Dechra Pharmaceuticals PLC
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Elanco Animal Health Incorporated
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Merck & Co., Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Norbrook Laboratories
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Prodivet Pharmaceuticals SA/NV
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Vetoquinol
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Virbac S.A.
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Zoetis Services LLC
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development

List of Tables:

Table 1 Global Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 2 Global Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 3 Global Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 4 North America: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 5 North America: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 6 North America: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 7 U.S.: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 8 U.S.: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 9 U.S.: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 10 Canada: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 11 Canada: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 12 Canada: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 13 Europe: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 14 Europe: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 15 Europe: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 16 UK: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 17 UK: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 18 UK: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 19 France: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 20 France: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 21 France: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 22 Germany: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 23 Germany: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 24 Germany: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 25 Italy: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 26 Italy: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 27 Italy: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 28 Spain: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 29 Spain: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 30 Spain: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 31 Netherlands: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 32 Netherlands: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 33 Netherlands: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 34 Russia: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 35 Russia: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 36 Russia: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 37 Rest of Europe: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 38 Rest of Europe: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 39 Rest of Europe: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 40 Asia Pacific: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 41 Asia Pacific: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 42 Asia Pacific: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 43 China: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 44 China: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 45 China: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 46 India: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 47 India: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 48 India: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 49 Malaysia: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 50 Malaysia: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 51 Malaysia: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 52 Japan: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 53 Japan: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 54 Japan: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 55 Indonesia: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 56 Indonesia: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 57 Indonesia: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 58 South Korea: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 59 South Korea: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 60 South Korea: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 61 Australia: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 62 Australia: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 63 Australia: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 64 Rest of Asia Pacific: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 65 Rest of Asia Pacific: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 66 Rest of Asia Pacific: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 67 Middle East & Africa: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 68 Middle East & Africa: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 69 Middle East & Africa: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 70 Saudi Arabia: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 71 Saudi Arabia: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 72 Saudi Arabia: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 73 UAE: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 74 UAE: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 75 UAE: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 76 Israel: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 77 Israel: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 78 Israel: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 79 South Africa: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 80 South Africa: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 81 South Africa: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 82 Rest of Middle East & Africa: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 83 Rest of Middle East & Africa: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 84 Rest of Middle East & Africa: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 85 Latin America: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 86 Latin America: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 87 Latin America: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 88 Mexico: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 89 Mexico: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 90 Mexico: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 91 Brazil: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 92 Brazil: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 93 Brazil: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 94 Argentina: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 95 Argentina: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 96 Argentina: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

Table 97 Rest of Latin America: Veterinary Antibiotics Market, by Animal Type, 2020-2034 (USD Billion)

Table 98 Rest of Latin America: Veterinary Antibiotics Market, by Drug Class, 2020-2034 (USD Billion)

Table 99 Rest of Latin America: Veterinary Antibiotics Market, by Dosage Form, 2020-2034 (USD Billion)

List of Figures:

Figure 1. Global Veterinary Antibiotics Market, 2020-2034 (USD Billion)

Figure 2. Integrated Ecosystem

Figure 3. Research Methodology: Top-Down & Bottom-Up Price

Figure 4. Market by Geography

Figure 5. Porter's Five Forces

Figure 6. Market by Animal Type

Figure 7. Global Veterinary Antibiotics Market, by Animal Type, 2024 & 2034 (USD Billion)

Figure 8. Market by Drug Class

Figure 9. Global Veterinary Antibiotics Market, by Drug Class, 2024 & 2034 (USD Billion)

Figure 10. Market by Dosage Form

Figure 11. Global Veterinary Antibiotics Market, by Dosage Form, 2024 & 2034 (USD Billion)